Metabolic profiling studies on the toxicological effects of realgar in rats by 1H NMR spectroscopy

Toxicology and Applied Pharmacology

Volumn 234, Issue 3, 2009, Pages 314-325

  Wei, Lai ^a   Liao, Peiqiu ^a   Wu, Huifeng ^a   Li, Xiaojing ^a   Pei, Fengkui ^a   Li, Weisheng ^a   Wu, Yijie ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

Liver extracts; Metabonomics; NMR; Pattern recognition; Realgar; Serum; Urine

Indexed keywords

ALANINE; ALKALINE PHOSPHATASE; ARSENIC DERIVATIVE; ASPARTATE AMINOTRANSFERASE; BETAINE; BIOLOGICAL MARKER; CHOLINE; CREATINE; CREATININE; GLUCOSE; GLUTAMIC ACID; GLUTATHIONE; GLYCOGEN; HIPPURIC ACID; KETONE BODY; LACTATE DEHYDROGENASE; METHIONINE; PHENYLACETYLGLYCINE; REALGAR; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; UREA;

ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID METABOLISM; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; CHINESE MEDICINE; CITRIC ACID CYCLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA FINGERPRINTING; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; HYPERTAURINURIA; HYPOGLYCEMIA; INTESTINE FLORA; KIDNEY; KIDNEY INJURY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LIVER INJURY; MALE; METABOLOMICS; METHYLATION; NONHUMAN; OXIDATIVE STRESS; PATTERN RECOGNITION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; UREA NITROGEN BLOOD LEVEL; URINALYSIS; WISTAR RAT;

ANIMALS; ARSENICALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; DRUGS, CHINESE HERBAL; ENERGY METABOLISM; INTESTINES; INTUBATION, GASTROINTESTINAL; KIDNEY; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; PATTERN RECOGNITION, AUTOMATED; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SULFIDES; TIME FACTORS; URINALYSIS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 58649121958     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.11.010     Document Type: Article

References (68)

1. Baker J.R., and Chaykin S. The biosynthesis of trimethylamine-N-oxide. J. Biol. Chem. 237 (1962) 1309-1313
2. Beckonert O., Keun H.C., Ebbels T.M., Bundy J., Holmes E., Lindon J.C., and Nicholson J.K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2 (2007) 2692-2703
3. Beckwith-Hall B.M., Holmes E., Lindon J.C., Gounarides J., Vickers A., Shapiro M., and Nicholson J.K. NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat. Chem. Res. Toxicol. 15 (2002) 1136-1141
4. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
5. 1H-NMR-based metabonomics. Nat. Med. 8 (2002) 1439-1444
6. 3 exerts dose-dependent dual effects on APL cells. Blood 89 (1997) 3345-3353
7. Chou W.C., and Dang C.V. Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies. Curr. Opin. Hematol. 12 (2005) 1-6
8. Clayton T.A., Lindon J.C., Everett J.R., Charuel C., Hanton G., Le Net J.L., Provost J.P., and Nicholson J.K. An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria. Arch. Toxicol. 77 (2003) 208-217
9. Coen M., Holmes E., Lindon J.C., and Nicholson J.K. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem. Res. Toxicol. 21 (2008) 9-27
10. Chinese Pharmacopeia Committee. Pharmacopoeia of China (2005), People's Press, Beijing, China
11. Daykin C.A., Van Duynhoven J.P., Groenewegen A., Dachtler M., Van Amelsvoort J.M., and Mulder T.P. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. J. Agric. Food Chem. 53 (2005) 1428-1434
12. Delaney J., Neville W.A., Swain A., Miles A., Leonard M.S., and Waterfield C.J. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model. Biomarkers 9 (2004) 271-290
13. Engelmann J., Henke J., Willker W., Kutscher B., Nossner G., Engel J., and Leibfritz D. Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. Anticancer Res. 16 (1996) 1429-1439
14. Felig P. The glucose-alanine cycle. Metabolism 22 (1973) 179-207
15. Gao T.A. Chinese Mineral Drugs and Their Application (1997), China Press of Traditional Chinese Medicine, Beijing 56-62
16. Gavaghan C.L., Wilson I.D., and Nicholson J.K. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett. 530 (2002) 191-196
17. Griffin J.L., Mann C.J., Scott J., Shoulders C.C., and Nicholson J.K. Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes. FEBS Lett. 509 (2001) 263-266
18. Griffin J.L., Cemal C.K., and Pook M.A. Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. Physiol. Genomics 16 (2004) 334-340
19. 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma. Anal. Chem. 78 (2006) 1546-1552
20. Holm P.I., Ueland P.M., Kvalheim G., and Lien E.A. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin. Chem. 49 (2003) 286-294
21. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11 (1998) 235-244
22. Im Y.S., Chiang P.K., and Cantoni G.L. Guanidoacetate methyltransferase. Purification and molecular properties. J. Biol. Chem. 254 (1979) 11047-11050
23. Keun H.C., Ebbels T.M.D., Antti H., Bollard M.E., Beckonert O., Holmes E., Lindon J.C., and Nicholson J.K. Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling. Anal. Chim. Acta 490 (2003) 265-276
24. Kitano H. A robustness-based approach to systems-oriented drug design. Nat. Rev. Drug Discov. 6 (2007) 202-210
25. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172 (2001) 249-261
26. Knowles S.E., Jarrett I.G., Filsell O.H., and Ballard F.J. Production and utilization of acetate in mammals. Biochem. J. 142 (1974) 401-411
27. Koch I., Sylvester S., Lai V.W., Owen A., Reimer K.J., and Cullen W.R. Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. Toxicol. Appl. Pharmacol. 222 (2007) 357-364
28. Kwan S.Y., Tsui S.K., and Man T.O. Release of soluble arsenic from realgar in simulated gastric juice. Anal. Lett. 34 (2001) 1431-1436
29. Lin C.Y., Wu H.F., Tjeerdema R.S., and Viant M.R. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3 (2007) 55-67
30. Lindon J.C., Nicholson J.K., and Everett J.R. NMR spectroscopy of biofluids. Annu. Rep. NMR Spectrosc. 38 (1999) 1-88
31. Lu D.P., Qiu J.Y., Jiang B., Wang Q., Liu K.Y., Liu Y.R., and Chen S.S. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 99 (2002) 3136-3143
32. Lutz N.W. Contributions of metabol(om)ic NMR spectroscopy to the investigation of apoptosis. C. R. Chim. 9 (2006) 445-451
33. Marchesi J.R., Holmes E., Khan F., Kochhar S., Scanlan P., Shanahan F., Wilson I.D., and Wang Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6 (2007) 546-551
34. McGarry J.D., and Foster D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 49 (1980) 395-420
35. McGregor D.O., Dellow W.J., Lever M., George P.M., Robson R.A., and Chambers S.T. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney Int. 59 (2001) 2267-2272
36. Mudd S.H., and Poole J.R. Labile methyl balances for normal humans on various dietary regimens. Metabolism 24 (1975) 721-735
37. Nicholson J.K., and Wilson I.D. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. Nucl. Magn. Reson. Spectrosc. 21 (1989) 449-501
38. Nicholson J.K., and Wilson I.D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2 (2003) 668-676
39. Nicholson J.K., Lindon J.C., and Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999) 1181-1189
40. Nicholson J.K., Connelly J., Lindon J.C., and Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1 (2002) 153-161
41. Phipps A.N., Stewart J., Wright B., and Wilson I.D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 28 (1998) 527-537
42. 1H-NMR of apoptosis and necrosis in HL60 leukemia cells: differences between the two types of cell death and independence from the stimulus of apoptosis used. Radiat. Res. 169 (2008) 170-180
43. Ralph S.J. Arsenic-based antineoplastic drugs and their mechanisms of action. Met. Based Drugs 2008 (2008) 260146
44. Reichl F.X., Szinicz L., Kreppel H., and Forth W. Effect of arsenic on carbohydrate metabolism after single or repeated injection in guinea pigs. Arch. Toxicol. 62 (1988) 473-475
45. 3). Arch. Toxicol. 64 (1990) 336-338
46. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89 (1997) 3354-3360
47. Smith J.L., Wishnok J.S., and Deen W.M. Metabolism and excretion of methylamines in rats. Toxicol. Appl. Pharmacol. 125 (1994) 296-308
48. 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal. Biochem. 323 (2003) 197-204
49. 3 on gluconeogenesis. Arch. Toxicol. 61 (1988) 444-449
50. Thomas D.J., Styblo M., and Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176 (2001) 127-144
51. 4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood 104 (2004) 4219-4225
52. Trygg J., Holmes E., and Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 6 (2007) 469-479
53. Wang Y., Tang H., Nicholson J.K., Hylands P.J., Sampson J., and Holmes E. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem. 53 (2005) 191-196
54. Wang Q., Jiang Y., Wu C., Zhao J., Yu S., Yuan B., Yan X., and Liao M. Study of a novel indolin-2-ketone compound Z24 induced hepatotoxicity by NMR-spectroscopy-based metabonomics of rat urine, blood plasma, and liver extracts. Toxicol. Appl. Pharmacol. 215 (2006) 71-82
55. Waterfield C.J., Turton J.A., Scales M.D., and Timbrell J.A. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Arch. Toxicol. 67 (1993) 244-254
56. Waters N.J., Holmes E., Williams A., Waterfield C.J., Farrant R.D., and Nicholson J.K. NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol. 14 (2001) 1401-1412
57. Waters N.J., Waterfield C.J., Farrant R.D., Holmes E., and Nicholson J.K. Integrated metabonomic analysis of bromobenzene-induced hepatotoxicity: novel induction of 5-oxoprolinosis. J. Proteome Res. 5 (2006) 1448-1459
58. Wei L., Liao P., Wu H., Li X., Pei F., Li W., and Wu Y. Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol. Appl. Pharmacol. 227 (2008) 417-429
59. Wold S., Trygg J., Berglund A., and Antti H. Some recent developments in PLS modeling. Chemometr. Intell. Lab. Syst. 58 (2001) 131-150
60. Wu X.H., Sun D.H., Zhuang Z.X., Wang X.R., Gong H.F., Hong J.X., and Lee F.S.C. Analysis and leaching characteristics of mercury and arsenic in Chinese medicinal material. Anal. Chim. Acta 453 (2002) 311-323
61. Wu H., Southam A.D., Hines A., and Viant M.R. High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal. Biochem. 372 (2008) 204-212
62. Wyss M., and Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80 (2000) 1107-1213
63. Xu L. Methods of Chemometrics (2004), Science Press, Beijing 221-227
64. Ye H.Q., Gan L., Yang X.L., and Xu H.B. Membrane-associated cytotoxicity induced by realgar in promyelocytic leukemia HL-60 cells. J. Ethnopharmacol. 103 (2006) 366-371
65. Zeisel S.H. Dietary choline: biochemistry, physiology, and pharmacology. Annu. Rev. Nutr. 1 (1981) 95-121
66. Zeisel S.H., Wishnok J.S., and Blusztajn J.K. Formation of methylamines from ingested choline and lecithin. J. Pharmacol. Exp. Ther. 225 (1983) 320-324
67. Zhang X., Wu H., Liao P., Li X., Ni J., and Pei F. NMR-based metabonomic study on the subacute toxicity of aristolochic acid in rats. Food Chem. Toxicol. 44 (2006) 1006-1014
68. Zhao X.H., Quan P., and Li J. Research on the cell apoptosis of leukemia induced by arsenic sulfide. J. Mod. Oncol. 14 (2006) 88-90